Anti-GAD antibodies in a cohort of neuropsychiatric patients
Conclusion Antiglutamate decarboxylase (anti-GAD) antibodies relate to epilepsy with or without cognitive complaints. However, psychiatric symptoms were almost absent in anti-GAD positive patients, and the presence of anti-GAD antibodies contributed little to the prognosis in our cohort.
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
More News: Brain | Children | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Epilepsy | Neurology | Psychiatry